Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02444325 · ClinicalTrials.gov registry record · NA

Diabetes Group Prenatal Care

A NA study of Type 2 Diabetes and Pregnancy, sponsored by Washington University School of Medicine.

Completed
Registry status
NA
Development phase
84
Enrollment target
2
Study locations

NCT02444325: Completed NA study of Type 2 Diabetes and Pregnancy, sponsored by Washington University School of Medicine.

NCT02444325 is a NA study of Type 2 Diabetes and Pregnancy that has completed, run by Washington University School of Medicine. The registered enrollment target is 84 participants, below the 3,923-participant average among 327 other Type 2 Diabetes trials with a reported enrollment target (98% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02444325, a NA study of Type 2 Diabetes and Pregnancy, has completed, sponsored by Washington University School of Medicine.

COMPLETED
Registry status
NA
Development phase
84 participants
Enrollment target
2
Study locations

Study Summary

The investigators primary objective is to conduct a pilot randomized trial to determine the effect of group prenatal care on self-care activities in women with diabetes.

Primary Outcome

Determine the effect of group prenatal care on maternal diabetes self-care activities as measured by the Diabetes Self-care Activities Measure and confirmed by percentage of recommended blood glucose values completed on logs since initial study visit.

Interventions

  • BEHAVIORAL Group prenatal care

Study Locations (2)

Colorado

  • Denver Health - Denver

Missouri

  • Washington University in St. Louis - St Louis

Trial Details

FieldValue
Enrollment Target 84 participants
Start Date 2015-05
Est. Completion 2017-09-27
Phase NA

What the finished NCT02444325 record still lists

NCT02444325 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 84 participants, a relatively small participant target, below the 3,923-participant average among 327 other Type 2 Diabetes trials with a reported enrollment target (98% lower).

The record links to 3 conditions, with Type 2 Diabetes appearing as the primary indexed condition, and to 1 intervention - of which Group prenatal care is the first listed.

NCT02444325 reports a single indexed study location in Colorado, Missouri.

Frequently Asked Questions

What is clinical trial NCT02444325 about?

NCT02444325 is a clinical study titled "Diabetes Group Prenatal Care". The investigators primary objective is to conduct a pilot randomized trial to determine the effect of group prenatal care on self-care activities in women with diabetes.

What is the current status of trial NCT02444325?

This trial is currently completed. It is a NA study. The enrollment target is 84 participants. The study started on 2015-05. Estimated completion is 2017-09-27.

What conditions does trial NCT02444325 study?

This clinical trial studies the following conditions: Type 2 Diabetes, Pregnancy, Gestational Diabetes.

What interventions are being tested in trial NCT02444325?

The interventions under investigation include: Group prenatal care (BEHAVIORAL).

Who is sponsoring clinical trial NCT02444325?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02444325 being conducted?

This trial has 2 study locations across Colorado, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type 2 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02444325's enrollment target sits among peer trials

84 171st of 327 higher than 155 of 327 other Type 2 Diabetes trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Type 2 Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02391519 · 84 participants

    Effects of High Altitude on AMPK Activation

  • NCT03838536 · 84 participants · NA

    Synergistic Activity of Human Milk Nutrients and Infant Cognition

  • NCT03884075 · 84 participants · Phase 2

    Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)

  • NCT03894917 · 84 participants

    Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02444325, the US trial registry maintained by the National Library of Medicine. NCT02444325 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.